Furthermore, a recent review suggested that results from previous studies on survival in CHEK2-associated breast cancer patients are inconclusive when keeping the design of most studies into account, and stated that further prospective studies with longer follow-up periods are needed to study the survival [28]. Here, CHEK2 is linked to breast carcinoma.